InVision Precision Cardiac Amyloid vs cV4 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by InVision Medical Technology
VS
by Samsung Medison

AI Verdict

Tool A is a specialized AI software designed for the precise detection of cardiac amyloidosis from echocardiogram studies, serving as a targeted diagnostic aid. In contrast, Tool B is a comprehensive diagnostic ultrasound hardware system that integrates AI to enhance image quality and automate measurements across various clinical applications, with a strong focus on OB/GYN. While both leverage AI in cardiovascular imaging, Tool A offers a specific disease detection capability, whereas Tool B provides a broader imaging platform with general AI-assisted functionalities.

Choose InVision Precision Cardiac Amyloid if…

Choose InVision Precision Cardiac Amyloid if your primary objective is to enhance the early and accurate detection of cardiac amyloidosis within your existing echocardiography workflow. This AI-powered software is specifically designed to analyze transthoracic echocardiogram studies, aiding clinicians in diagnosing and assessing patients with heart failure symptoms for both AL and ATTR types of the disease.

View InVision Precision Cardiac Amyloid →

Choose cV4 Diagnostic Ultrasound System if…

Choose the Samsung Medison cV4 Diagnostic Ultrasound System if your facility requires a versatile, AI-enabled hardware ultrasound solution for a broad spectrum of diagnostic applications across multiple specialties. This system offers advanced imaging quality and AI-powered features for areas such as maternal-fetal medicine, obstetrics & gynecology, and general radiology, while also providing robust data security and a silent, fanless operation.

View cV4 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature InVision Precision Cardiac Amyloid cV4 Diagnostic Ultrasound System
Deployment Cloud or on-premise On-premise
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

InVision Precision Cardiac Amyloid

Tool A, as a Software as a Medical Device (SaMD), is designed to integrate into existing clinical workflows for echocardiography labs, which generally implies lower friction for adoption and daily use. In contrast, Tool B is a physical hardware device, requiring new system learning and physical deployment, even with its own streamlined AI-powered workflows.

Clinical Value

InVision Precision Cardiac Amyloid

Tool A offers AI-powered detection of cardiac amyloidosis, a life-threatening and often underdiagnosed disease, aiming for earlier detection and reduction of misdiagnosis. Its evidence-based algorithm has been peer-reviewed and published in JAMA Cardiology, indicating significant and validated clinical impact on a critical condition.

Pricing & Value

InVision Precision Cardiac Amyloid

Tool A provides transparent, subscription-based pricing starting at an accessible $49/month, with enterprise options available, making its cost-effectiveness clear. Tool B requires contacting for pricing, which is typical for a capital expenditure hardware device but lacks transparency, making direct value comparison difficult.

Enterprise Readiness

InVision Precision Cardiac Amyloid

Both tools are FDA-cleared and HIPAA compliant, but Tool A's deployment as SaMD, integrated into existing workflows, along with explicit mention of enterprise pricing and volume discounts, suggests a more scalable and potentially smoother adoption for large healthcare systems. Tool B, while having robust cybersecurity for a hardware device, involves physical deployment which can be a larger hurdle for widespread enterprise rollout.

Innovation

cV4 Diagnostic Ultrasound System

Tool B demonstrates broader innovation with its 'world's first fanless design' for silent operation and extended lifespan, alongside multiple AI-powered assists (HeartAssistu2122, NerveTracku2122, BiometryAssistu2122, LaborAssistu2122) across diverse clinical applications. While Tool A offers significant, clinically validated AI innovation in a specific niche, Tool B's combined hardware and multi-application AI advancements are more expansive.

Support & Docs

cV4 Diagnostic Ultrasound System

As a product from Samsung Medison, a large and established medical device manufacturer, Tool B likely benefits from a comprehensive global support network, extensive documentation, and structured training resources. InVision Medical Technology, while offering contact options, appears to be a more specialized software company, and typically, larger hardware manufacturers have more extensive support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature InVision Precision Cardiac Amyloid cV4 Diagnostic Ultrasound System
Name InVision Precision Cardiac Amyloid cV4 Diagnostic Ultrasound System
Company InVision Medical Technology Corporation Samsung Medison Co.
Description AI-powered software for echocardiography to detect cardiac amyloidosis, a life-threatening and often underdiagnosed disease, aiming for earlier detection and improved patient outcomes. The Samsung Medison cV4 is an AI-enabled, fanless diagnostic ultrasound system offering advanced imaging, streamlined workflows, and robust data security for diverse clinical applications.
Primary Clinical Focus Cardiac Amyloidosis detection via echocardiography Diagnostic ultrasound for diverse clinical applications (Cardiology, OB/GYN, Radiology)
Key AI Features AI-powered detection of cardiac amyloidosis, evaluation of transthoracic echocardiogram studies, precise assessment of wall thickness. AI-powered HeartAssistu2122, NerveTracku2122, BiometryAssistu2122, LaborAssistu2122
Specialties Cardiology, Radiology Maternal-Fetal Medicine, Obstetrics & Gynecology, Radiology

Videos

Demos, reviews, and walkthroughs featuring InVision Precision Cardiac Amyloid and cV4 Diagnostic Ultrasound System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

InVision Precision Cardiac Amyloid is AI-powered software specifically designed for echocardiography to detect cardiac amyloidosis, aiming for earlier detection and improved patient outcomes. The Samsung Medison cV4 Diagnostic Ultrasound System is an AI-enabled hardware device offering advanced imaging and streamlined workflows for diverse clinical applications, including AI-powered features for fetal heart assessment, nerve detection, and automated fetal measurements.
InVision Precision Cardiac Amyloid is a Software as a Medical Device (SaMD) that integrates into existing clinical workflows for echocardiography labs, analyzing transthoracic echocardiogram studies. The Samsung Medison cV4 is an on-premise physical hardware device, a diagnostic ultrasound system that generates its own images and includes AI features for real-time analysis.
InVision Precision Cardiac Amyloid provides AI-powered detection and assessment of both AL and ATTR Cardiac Amyloidosis, evaluating apical-4-chamber and parasternal-long-axis view videos for diagnosis and precise wall thickness assessment. The Samsung Medison cV4 features AI-powered HeartAssist for automated fetal heart assessment, NerveTrack for real-time nerve detection, BiometryAssist for automated fetal measurements, and LaborAssist for fetal angle of progression estimation.
InVision Precision Cardiac Amyloid is a software solution designed to evaluate existing transthoracic echocardiogram studies, integrating into current echocardiography lab workflows without requiring new ultrasound hardware. In contrast, the Samsung Medison cV4 Diagnostic Ultrasound System is a physical hardware device, meaning it is a new ultrasound machine acquisition rather than a software add-on to existing equipment.
InVision Precision Cardiac Amyloid's AI algorithm is evidence-based, peer-reviewed, and has been published in JAMA Cardiology. The Samsung Medison cV4 includes AI features like HeartAssist and NerveTrack, which have undergone testing for performance and accuracy, with the system complying with FDA-recognized standards.
AI Tool Finder
AI-powered search. Results may not be comprehensive.